Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Accounts Payable

$429.50M

Quarterly · Period ending: Jun 30, 2026 · USD

VRTX Accounts Payable

Latest reported$429.50Mperiod endingJun 30, 2026

Latest reported$429.50Mperiod endingJun 30, 2026

VRTX Quarterly Accounts Payable ($0.00 → $429.50M)

Quarterly accounts payable

High-resolution chart · PNG

VRTX accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2001	6,362,000
Mar 31, 2001	2,596,000
Dec 31, 2000	8,438,000
Sep 30, 2000	31,387,000
Jun 30, 2000	17,645,000
Mar 31, 2000	13,767,000
Dec 31, 1999	14,152,000
Sep 30, 1999	10,600,000
Jun 30, 1999	11,700,000
Mar 31, 1999	11,100,000
Dec 31, 1998	2,800,000
Sep 30, 1998	8,300,000
Jun 30, 1998	6,000,000
Mar 31, 1998	6,200,000
Dec 31, 1997	4,200,000
Sep 30, 1997	8,500,000
Jun 30, 1997	5,400,000
Mar 31, 1997	6,300,000
Dec 31, 1996	1,400,000
Sep 30, 1996	2,900,000
Jun 30, 1996	4,100,000
Mar 31, 1996	4,200,000
Dec 31, 1995	3,000,000
Sep 30, 1995	5,700,000
Jun 30, 1995	5,800,000
Mar 31, 1995	3,600,000
Dec 31, 1994	1,400,000
Sep 30, 1994	4,100,000
Jun 30, 1994	3,600,000
Mar 31, 1994	2,800,000
Dec 31, 1993	3,500,000
Sep 30, 1993	2,700,000
Jun 30, 1993	1,900,000
Mar 31, 1993	2,500,000
Dec 31, 1992	700,000
Sep 30, 1992	0
Jun 30, 1992	1,200,000
Mar 31, 1992	1,000,000
Dec 31, 1991	800,000
Sep 30, 1991	900,000
Jun 30, 1991	900,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.